BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23736366)

  • 1. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
    Asmar M; Simonsen L; Arngrim N; Holst JJ; Dela F; Bülow J
    Int J Obes (Lond); 2014 Feb; 38(2):259-65. PubMed ID: 23736366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss.
    Asmar M; Arngrim N; Simonsen L; Asmar A; Nordby P; Holst JJ; Bülow J
    Nutr Diabetes; 2016 May; 6(5):e208. PubMed ID: 27136446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
    Asmar M; Simonsen L; Madsbad S; Stallknecht B; Holst JJ; Bülow J
    Diabetes; 2010 Sep; 59(9):2160-3. PubMed ID: 20547981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans.
    Asmar M; Simonsen L; Asmar A; Holst JJ; Dela F; Bülow J
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3155-62. PubMed ID: 27258938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor.
    Asmar M; Asmar A; Simonsen L; Gasbjerg LS; Sparre-Ulrich AH; Rosenkilde MM; Hartmann B; Dela F; Holst JJ; Bülow J
    Diabetes; 2017 Sep; 66(9):2363-2371. PubMed ID: 28667118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIP-induced vasodilation in human adipose tissue involves capillary recruitment.
    Asmar M; Asmar A; Simonsen L; Dela F; Holst JJ; Bülow J
    Endocr Connect; 2019 Jun; 8(6):806-813. PubMed ID: 31063975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue.
    Pivovarova O; Gögebakan O; Osterhoff MA; Nauck M; Pfeiffer AF; Rudovich N
    Regul Pept; 2012 Nov; 179(1-3):29-32. PubMed ID: 22960196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
    Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endogenous GIP in patients with type 2 diabetes.
    Stensen S; Gasbjerg LS; Krogh LL; Skov-Jeppesen K; Sparre-Ulrich AH; Jensen MH; Dela F; Hartmann B; Vilsbøll T; Holst JJ; Rosenkilde MM; Christensen MB; Knop FK
    Eur J Endocrinol; 2021 May; 185(1):33-45. PubMed ID: 33886495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
    Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
    Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity.
    Roust LR; Stesin M; Go VL; O'Brien PC; Rizza RA; Service FJ
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E767-74. PubMed ID: 3287953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.
    Younan SM; Rashed LA
    Gen Physiol Biophys; 2007 Sep; 26(3):181-93. PubMed ID: 18063845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide.
    Solomon TP; Haus JM; Kelly KR; Rocco M; Kashyap SR; Kirwan JP
    Diabetes Care; 2010 Jul; 33(7):1561-6. PubMed ID: 20200305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.